Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation

Journal of Endocrinology

Volumn 198, Issue 2, 2008, Pages 317-330

  Miquet, Johanna G ^a   González, Lorena ^a   Matos, Marina N ^a   Hansen, Christina E ^b   Louis, Audreen ^b   Bartke, Andrzej ^b   Turyn, Daniel ^a   Sotelo, Ana I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; GROWTH HORMONE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STAT3 PROTEIN; STAT5 PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; GENOTYPE; HORMONAL REGULATION; IMMUNOPRECIPITATION; LIVER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION;

EID: 51349161232     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0002     Document Type: Article

References (69)

1. Abram CL & Courtneidge SA 2000 Src family tyrosine kinases and growth factor signaling. Experimental Cell Research 254 1-13.
2. Aguilar RC, Fernández HN, Dellacha JM, Calandra RS, Bartke A, Ghosh PK & Turyn D 1992 Somatotropic and lactotropic receptors in transgenic mice expressing human and bovine growth hormone. Transgenic Research 1 221-227.
3. Bartke A 2003 Can growth hormone accelerate aging? Evidence from GH-transgenic mice Neuroendocrinology 78 210-216.
4. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH & Parsons SJ 1999 c-Src mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. Journal of Biological Chemistry 274 8335-8343.
5. Biscardi JS, Ishizawar RC, Silva CM & Parsons SJ 2000 Tyrosine kinase signaling in breast cancer - epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Research 2 203-210.
6. Bjorge JD, Jakymiw A & Fujita DJ 2000 Selected glimpses into the activation and function of Stc kinase. Oncogene 19 5620-5635.
7. Boggon TJ & Eck MJ 2004 Structure and regulation of Src family kinases. Oncogene 23 7918-7927.
8. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 248-254.
9. Brooks AJ, Wooh JW, Tunny KA & Waters MJ 2007 Growth hormone receptor; mechanism of action. International Journal of Biochemistry and Cell Biology. DOI:10.1016/j.biocel.2007.07.008.
10. Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N & Russo A 2003 STAT proteins: from normal control of cellular events to tumorigenesis. Journal of Cellular Physiology 197 157-168.
11. Chambard JC, Lefloch R, Pouysségur J & Lenormand P 2007 Erk implication in cell cycle regulation. Biochimica et Biophysica Acta 1773 1299-1310.
12. Chang L & Karin M 2001 Mammalian MAP kinase signaling cascades. Nature 410 37-40.
13. Chomczynski P & Saachi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
14. Dann SG, Selvaraj A & Thomas G 2007 mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends in Molecular Medicine 13 252-259.
15. Davidson MB 1987 Effects of growth hormone on carbohydrate and lipid metabolism. Endocrine Reviews 8 115-131.
16. Dominici FP, Cifone D, Bartke A & Turyn D 1999 Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. Journal of Endocrinology 161 383-392.
17. Dominici FP, Argentino DP, Muñoz MC, Miquet JG, Sotelo AT & Turyn D 2005 Influence of the crosstalk between growth hormone and insulin signaling on the modulation of insulin sensitivity. Growth Hormone and IGF Research 15 324-336.
18. Ekberg S, Carlsson L, Carlsson B, Billig H & Jansson JO 1989 Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver. Endocrinology 125 2158-2166.
19. Frank SJ 2001 Growth hormone signaling and its regulation: preventing too much of a good thing. Growth Hormone and IGF Research 11 201-212.
20. Frank SJ 2002 Receptor dimerization in GH and Erytropoietin action: it takes two to tango, but how? Endocrinology 143 2-10.
21. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV & Wells JA 1992 Rational design of potent antagonists to the human growth hormone receptor. Science 256 1677-1680.
22. González L, Sotelo AI, Bartke A & Turyn D 2001 Growth hormone (GH) and estradiol regulation of membrane-associated GH binding protein and GH receptors in GH releasing hormone transgenic mice. Growth Hormone and IGF Research 11 34-40.
23. González L, Miquet JG, Sotelo AI, Bartke A & Turyn D 2002 Cytokine inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice. Endocrinology 143 286-294.
24. González L, Curto LM, Miquet JG, Bartke A, Turyn D & Sotelo AI 2007 Differential regulation of membrane associated-growth hormone binding protein (MA-GHBP) and growth hormone receptor (GHR) expression by growth hormone (GH) in mouse liver. Growth Hormone and IGF Research 17 104-112.
25. Hayashi AA & Proud CG 2007 The rapid activation of protein synthesis by growth hormone requires signaling through the mammalian target of rapamycin, mTOR. American Journal of Physiology. Endocrinology and Metabolism 292 E1647-E1655.
26. Herrington J, Smit LS, Schwartz J & Carter-Su C 2000 The role of STAT proteins in growth hormone signaling. Oncogene 19 2585-2597.
27. Hidalgo M & Rowinsky EK 2000 The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19 6680-6686.
28. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, Kolb HJ, Wanke R & Wolf E 2001 Growth inhibition in giant transgenic mice by overexpression of insuhn-like growth factor binding protein-2. Endocrinology 142 1889-1898.
29. Holbro T, Civenni G & Hynes NE 2003 The ErbB receptors and their role in cancer progression. Experimental Cell Research 284 99-110.
30. Iida K, Del Rincon JP, Kim DS, Itoh E, Nass R, Coschigano KT, Kopchick JJ & Thorner MO 2004 Tissue specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. Endocrinology 145 1564-1570.
31. Jansson JO, Ekberg S, Hoath SB, Beamer WG & Frohman LA 1988 Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice. Journal of Clinical Investigation 82 1871-1879.
32. Jenkins PJ & Besser M 2001 Acromegaly and cancer: a problem. Journal of Clinical Endocrinology and Metabolism 86 2935-2941.
33. Jorgensen JO, Krag M, Jessen N, Norrelund H, Vestergaard ET, Moller N & Christi JS 2004 Growth hormone and glucose metabolism. Hormone Research 62 51-55.
34. Landsman T & Waxman DJ 2005 Role of cytokine-induced SH2 domain-containing CIS in growth hormone receptor internalization. Journal of Biological Chemistry 280 37471-37480.
35. Lanning NJ & Carter-Su C 2007 Recent advances in growth hormone signaling. Reviews in Endocrine and Metabolic Disorders 7 225-235.
36. Manabe N, Kubota Y, Kitanaka A, Ohnishi H, Taminato T & Tanaka T 2006 Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells. Leukemia Research 30 1391-1398.
37. Masternak MM, Al-Regaiey KA, Del Rosario Lim MM, Bonkowski MS, Panici JA, Przybylski GK & Bartke A 2005 Caloric restriction results in decreased expression of peroxisome proliferators-activated receptors (PPARs) superfamily in muscle of normal and long-lived GHR-KO mice. Journal of Gerontology. Series A, Biological Sciences and Medical Sciences 60A 1238-1245.
38. Mathews LS, Hammer RE, Brinster RL & Palmiter RD 1988 Expression of insulin-hke growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123 433-437.
39. Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenveld MG & Evans RM 1988 Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone releasing factor gene. Molecular Endocrinology 2 606-612.
40. McGrane MM, Yun JS, Moorman AFM, Lamers WH, Hendrick GK, Arafah BM, Park EA, Wagner TE & Hanson RW 1990 Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. Journal of Biological Chemistry 265 22371-22379.
41. Miquet JG, Sotelo AI, Bartke A & Turyn D 2004 Suppression of growth hormone (GH) JAK2/STAT5 signaling pathway in transgenic mice overexpressing bovine GH. Endocrinology 145 2824-2832.
42. Miquet JG, Sotelo AI, Bartke A & Turyn D 2005 Increased SH2-Bβ content and membrane association in transgenic mice overexpressing GH. Journal of Endocrinology 185 301-306.
43. Nicholson KM & Anderson NG 2002 The protein kinase B/Akt signaling pathway in human malignancy. Cellular Signalling 14 381-395.
44. Orian JM, Lee CS, Weiss LM & Brandon MR 1989 The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver. Endocrinology 124 455-463.
45. Orian JM, Tamakoshi K, Mackay IR & Brandon MR 1990 New murine model of hepatocellular carcinoma: transgenic mice expressing metallothionein-ovine growth hormone fusion gene. Journal of the National Cancer Institute 82 393-398.
46. Parsons JT 2003 Focal adhesion kinase: the first ten years. Journal of Cell Science 116 1409-1416.
47. Parsons SJ & Parsons JT 2004 Src family kinases, key regulators of signal transduction. Oncogene 23 7906-7909.
48. Perry JK, Emerald BS, Mertani HC & Lobie PE 2006 The oncogenic potential of growth hormone. Growth Hormone and IGF Research 16 277-289.
49. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL & Palmiter RD 1989 Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124 40-48.
50. Ram P & Waxman DJ 2000 Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. Journal of Biological Chemistry 275 39487-39496.
51. Ram PA, Park SH, Choi HK & Waxman DJ 1996 Growth hormone activation of STAT1, STAT3, and STAT5 in rat liver. Journal of Biological Chemistry 271 5926-5940.
52. Schlaepfer DD & Mitra SK 2004 Multiple connections link FAK to cell motility and invasion. Current Opinion in Genetics and Development 14 92-101.
53. Silva CM 2004 Role of STATs as downstream signal trasducers in Src family kinase-mediated tumorigenesis. Oncogene 23 8017-8023.
54. Snibson KJ 2002 Hepatocellular kinetics and the expression of growth hormone (GH) in the livers and liver tumours of GH-transgenic mice. Tissue and Cell 34 88-97.
55. Snibson KJ, Bhathal PS, Hardy CL, Brandon MR & Adams TE 1999 High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice. Liver 19 242-252
56. Song G, Ouyang G & Bao S 2005 The activation of Akt/PKB signaling pathway and cell survival. Journal of Cellular and Molecular Medicine 9 59-71.
57. Sotelo AI, Dominici FP, Engbers C, Bartke A, Talamantes F & Turyn D 1995 Growth hormone binding protein (GHBP) in normal mice and in transgenic mice expressing bovine growth hormone gene. American Journal of Physiology 268 E745-E751.
58. Sotelo AI, Bartke A, Kopchick JJ, Knapp JR & Turyn D 1998 Growth hormone (GH) receptors and binding proteins and IGF-I concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist. Journal of Endocrinology 158 53-59.
59. Sotelo AI, Miquet JG, González L, Bartke A & Turyn D 2008 Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues. Growth Hormone and IGF Research 10 148-156.
60. Thomas SM & Brugge JS 1997 Cellular functions regulated by Src family kinases. Annual Review of Cell and Developmental Biology 13 513-609.
61. Thomas MB & Zhu AX 2005 Hepatocellular carcinoma: the need for progress. Journal of Clinical Oncology 23 2892-2899.
62. Uyttendaele I, Lemmens I, Verhee A, De Smet AS, Vandekerckhove J, Lavens D, Peelman F & Tavernier J 2007 MAPPIT analysis of STAT5, CIS and SOCS2 interactions with the growth hormone receptor. Molecular Endocrinology 21 2821-2831.
63. Wang Z, Masternak MM, Al-Pegaiey KA & Bartke A 2007 Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148 2845-2853.
64. Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA & Brown RJ 2006 New insights into growth hormone action. Journal of Molecular Endocrinology 36 1-7.
65. Woelfle J & Rotwein P 2004 In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. American Journal of Physiology. Endocrinology and Metabolism 286 E393-E401.
66. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahasshi M, Takahasshi T, Matsuda T et al. 1997 Tyrosine phosphorylation of the EGF receptor by the kinase JAK2 is induced by growth hormone. Nature 390 91-96.
67. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H et al. 1998 Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocrine Journal 43 27-31.
68. Zhu T, Goh EL, Graichen R, Ling L & Lobie PE 2001 Signal transduction via the growth hormone receptor. Cellular Signalling 13 599-616.
69. Zhu T, Ling L & Lobie PE 2002 Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent. Journal of Biological Chemistry 277 45592-45603.